These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38607240)

  • 1. Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1.
    Lai Q; Wan Y; Zhang Y; Huang Y; Tang Q; Chen M; Li Q; Ma K; Xiao P; Luo C; Zhuang X
    Mol Carcinog; 2024 Jul; 63(7):1260-1274. PubMed ID: 38607240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAR2 Promoter Hypomethylation Regulates PAR2 Gene Expression and Promotes Lung Adenocarcinoma Cell Progression.
    Wu K; Xu L; Cheng L
    Comput Math Methods Med; 2021; 2021():5542485. PubMed ID: 33968158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of CLEC14A is associated with its expression and lung adenocarcinoma progression.
    Su C; Shi K; Cheng X; Han Y; Li Y; Yu D; Liu Z
    J Cell Physiol; 2019 Mar; 234(3):2954-2962. PubMed ID: 30191970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine-mediated LINC01087 promotes lung adenocarcinoma progression by regulating miR-514a-3p to upregulate centrosome protein 55.
    Zhang X; Wang DJ; Jia L; Zhang W
    Kaohsiung J Med Sci; 2024 Sep; 40(9):801-818. PubMed ID: 39023191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.
    Zhao W; Liu Y; Yang Y; Wang L
    BMC Cancer; 2024 May; 24(1):635. PubMed ID: 38783241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis.
    Liu S; Liu X; Yang Q; Zeng C; Hu G; Ren B
    J Pharm Pharmacol; 2024 Jul; 76(7):873-883. PubMed ID: 38698658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
    Kang H; Ma D; Zhang J; Zhao J; Yang M
    BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01116-dependent upregulation of RNA polymerase I transcription drives oncogenic phenotypes in lung adenocarcinoma.
    Sarkar SS; Sharma M; Saproo S; Naidu S
    J Transl Med; 2024 Oct; 22(1):904. PubMed ID: 39369230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.
    Xu D; Wang Z; Li F
    Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGO2 as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma.
    Chen Y; Xiang T
    Front Biosci (Landmark Ed); 2024 Aug; 29(9):314. PubMed ID: 39344317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR-486-5p/NEK2 axis.
    Fu H; Zhang M; Liu X; Yang Y; Xing Y
    Clin Respir J; 2024 May; 18(5):e13765. PubMed ID: 38721812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker 
for Lung Adenocarcinoma].
    Zhang R; Huang H; Zhu G; Wu D; Chen C; Cao P; Ding C; Liu H; Chen J; Li Y
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):25-37. PubMed ID: 38296623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of long noncoding RNA LINC00924 in lung adenocarcinoma and its regulatory effect on tumor progression.
    Zhang W; Zhao Y; Jia Y; Bai Y
    Histol Histopathol; 2024 May; 39(5):595-602. PubMed ID: 37358073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
    Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
    Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.
    Li J; He X; Wu X; Liu X; Huang Y; Gong Y
    Comput Math Methods Med; 2020; 2020():2953598. PubMed ID: 33204298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
    Liu J; Pan C; Lu R; Zhang S
    Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation and transcriptome analyses construct a prognostic model and reveal the suppressor role of VMO1 in lung adenocarcinoma.
    Wang L; Yin M; Zhang Z; Liu S; Liu Y; Geng X; Zheng G
    Cell Signal; 2024 Oct; 122():111313. PubMed ID: 39053673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.